Spinal Muscular Atrophy Type 3 Latest Advances

Autonomic Nervous System Phenotyping Across Chronic Demyelinating Peripheral Neuropathies: A Comparative Study.

Journal: Journal of the peripheral nervous system : JPNS

Published: May 25, 2026

Hirayama disease: an uncommon cause of motor neuron disease.

Journal: Arquivos de neuro-psiquiatria

Published: March 19, 2026

Multisystem Complications in Spinal Muscular Atrophy Type III: Chronic Respiratory Failure and Intractable Epilepsy.

Journal: Cureus

Published: March 16, 2026

Impairment of lip and tongue strength in symptomatic SMA1 patients: Results from a 4-center prospective study using the IOPI.

Journal: Journal of neuromuscular diseases

Published: March 14, 2026

Risdiplam therapy in adult patients with Spinal muscular Atrophy (SMA). A 24-month-real-world experience at a single muscular centre.

Journal: Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology

Published: March 12, 2026

Learning outcomes of infants and young children with spinal muscular atrophy type I provided with modified-electric-toy-cars in their natural environment.

Journal: Assistive technology : the official journal of RESNA

Published: March 10, 2026

When Neuromuscular Weakness Is Not Chemotherapy‑Related: Spinal Muscular Atrophy Type II Diagnosed After Acute Lymphoblastic Leukemia Onset in a 1-Year-Old Child: A Case Report and Review of the Literature.

Journal: Pediatric blood & cancer

Published: March 05, 2026

Relationships between home and community participation, social-cognitive skills, and powered mobility learning in children with SMA type I: A randomized, waiting-list controlled trial.

Journal: Assistive technology : the official journal of RESNA

Published: February 17, 2026

Hirayama disease - A case report and literature review.

Journal: Surgical neurology international

Published: February 04, 2026

Systemic AAV9 Gene Therapy Mitigates Neuromuscular Junction Degeneration and Muscle Atrophy in a Mouse Model of CLN1 Disease.

Journal: International journal of molecular sciences

Published: January 27, 2026

Fusionless spinal surgery in children with spinal muscular atrophy type 1 with bipolar system: a preliminary communication.

Journal: Journal of pediatric orthopedics. Part B

Published: January 22, 2026

Restless Legs Syndrome in Patients With PMP22-Related Neuropathies.

Journal: Journal of the peripheral nervous system : JPNS

Published: January 13, 2026

Spinal Muscular Atrophy Type 3 Latest Advances

Find the Latest Research About Spinal Muscular Atrophy Type 3

Autonomic Nervous System Phenotyping Across Chronic Demyelinating Peripheral Neuropathies: A Comparative Study.

Autonomic Nervous System Phenotyping Across Chronic Demyelinating Peripheral Neuropathies: A Comparative Study.

Hirayama disease: an uncommon cause of motor neuron disease.

Hirayama disease: an uncommon cause of motor neuron disease.

Multisystem Complications in Spinal Muscular Atrophy Type III: Chronic Respiratory Failure and Intractable Epilepsy.

Multisystem Complications in Spinal Muscular Atrophy Type III: Chronic Respiratory Failure and Intractable Epilepsy.

Impairment of lip and tongue strength in symptomatic SMA1 patients: Results from a 4-center prospective study using the IOPI.

Impairment of lip and tongue strength in symptomatic SMA1 patients: Results from a 4-center prospective study using the IOPI.

Risdiplam therapy in adult patients with Spinal muscular Atrophy (SMA). A 24-month-real-world experience at a single muscular centre.

Risdiplam therapy in adult patients with Spinal muscular Atrophy (SMA). A 24-month-real-world experience at a single muscular centre.

Learning outcomes of infants and young children with spinal muscular atrophy type I provided with modified-electric-toy-cars in their natural environment.

Learning outcomes of infants and young children with spinal muscular atrophy type I provided with modified-electric-toy-cars in their natural environment.

When Neuromuscular Weakness Is Not Chemotherapy‑Related: Spinal Muscular Atrophy Type II Diagnosed After Acute Lymphoblastic Leukemia Onset in a 1-Year-Old Child: A Case Report and Review of the Literature.

When Neuromuscular Weakness Is Not Chemotherapy‑Related: Spinal Muscular Atrophy Type II Diagnosed After Acute Lymphoblastic Leukemia Onset in a 1-Year-Old Child: A Case Report and Review of the Literature.

Relationships between home and community participation, social-cognitive skills, and powered mobility learning in children with SMA type I: A randomized, waiting-list controlled trial.

Relationships between home and community participation, social-cognitive skills, and powered mobility learning in children with SMA type I: A randomized, waiting-list controlled trial.

Hirayama disease - A case report and literature review.

Hirayama disease - A case report and literature review.

Systemic AAV9 Gene Therapy Mitigates Neuromuscular Junction Degeneration and Muscle Atrophy in a Mouse Model of CLN1 Disease.

Systemic AAV9 Gene Therapy Mitigates Neuromuscular Junction Degeneration and Muscle Atrophy in a Mouse Model of CLN1 Disease.

Fusionless spinal surgery in children with spinal muscular atrophy type 1 with bipolar system: a preliminary communication.

Fusionless spinal surgery in children with spinal muscular atrophy type 1 with bipolar system: a preliminary communication.

Restless Legs Syndrome in Patients With PMP22-Related Neuropathies.

Restless Legs Syndrome in Patients With PMP22-Related Neuropathies.